Company Profile

Health Technology Innovations LLC (AKA: HTI)
Profile last edited on: 11/13/2020      CAGE: 5NW51      UEI: SKHEZ9ANNR43

Business Identifier: Accelerates drug discovery for Biotech and Pharma companies
Year Founded
----
First Award
2020
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4640 SW Macadam Avenue Suite 200D
Portland, OR 97239
   (503) 539-9528
   N/A
   www.healthtechnologyinnovations.com
Location: Single
Congr. District: 01
County: Multnomah

Public Profile

Employing artificial intelligence and machine learning, Health Technology Innovations (HTI) is developing advanced medical image processing solutions. The firm is accelerating drug discovery for Biotech and Pharma companies by providing structure determination services using cryogenic-electron microscopy (cryo-EM) and machine-learning based image processing software. The firm is partnering with leading research institutions and cryo-EM centers to improve processing and analysis of large imaging datasets using cryogenic electron microscopy (cryo-EM), the Nobel Prize-winning imaging method that is revolutionizing structural biology.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NSF $1,224,905
Project Title: CryoDiscovery? : an integrated cryo-EM intelligence solution

Key People / Management

  Narasimha Kumar -- Founder and CEO

  Tuan Phamdo -- CEO

  Shiva Aditham -- VP Engineering & Development

  Kennedy Brown -- VP Market & Business Development

  Gershon Wolfe -- Director of Research & Development

  Craig Yoshiaka -- Co-Principal Investigator

Company News

There are no news available.